Stryker expresses satisfaction with Q1 2015 financial performance

Stryker has announced its financial results for the first quarter of 2015, during which it achieved a net sales total of $2.4 billion (1.6 billion pounds).

This represents a 3.2 percent increase on the same period last year, while its organic sales growth total reached nearly six percent and its adjusted diluted net earnings per share increased 4.7 percent.

Its orthopaedics, MedSurg, and neurotechnology and spine divisions all experienced improved performances, thanks to increased unit volumes and disciplined expense management helping to overcome negative currency trends.

The company now expects 2015 constant currency sales growth to be in the range of six to seven percent.

Kevin Lobo, chairman and chief executive officer at Stryker, said: "We expect this momentum, which is balanced across segments and regions, to continue and are raising the low end of full-year sales and earnings guidance."

The firm was ranked as the 19th best US-based company to work for in an annual list compiled by Fortune magazine last month.